Credit Suisse Group Initiates Coverage on Encompass Health (EHC)

Equities researchers at Credit Suisse Group started coverage on shares of Encompass Health (AMEX:EHC) in a research report issued on Wednesday. The brokerage set an “outperform” rating on the stock.

EHC has been the topic of a number of other research reports. SunTrust Banks set a $58.00 price objective on shares of Encompass Health and gave the company a “buy” rating in a research note on Thursday, December 21st. Zacks Investment Research upgraded shares of Encompass Health from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Royal Bank of Canada reiterated a “buy” rating on shares of Encompass Health in a research note on Wednesday, November 15th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Tuesday, November 21st. Finally, Stephens reiterated a “buy” rating and set a $55.00 price objective on shares of Encompass Health in a research note on Friday, January 12th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $53.11.

Encompass Health (AMEX:EHC) opened at $51.31 on Wednesday. Encompass Health has a 1-year low of $38.24 and a 1-year high of $52.58. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. The company has a market cap of $4,860.00, a P/E ratio of 18.73, a P/E/G ratio of 1.70 and a beta of 0.54.

Encompass Health (AMEX:EHC) last posted its quarterly earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The firm had revenue of $995.60 million for the quarter, compared to analyst estimates of $985.75 million. During the same quarter last year, the firm posted $0.65 earnings per share. Encompass Health’s revenue for the quarter was up 7.4% compared to the same quarter last year. equities analysts expect that Encompass Health will post 2.72 EPS for the current fiscal year.

In related news, Director Yvonne M. Curl purchased 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The stock was acquired at an average price of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the purchase, the director now owns 64,144 shares in the company, valued at $2,947,416.80. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by insiders.

A hedge fund recently bought a new stake in Encompass Health stock. Nisa Investment Advisors LLC purchased a new position in Encompass Health Corp (AMEX:EHC) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 23,420 shares of the company’s stock, valued at approximately $1,157,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Credit Suisse Group Initiates Coverage on Encompass Health (EHC)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with's FREE daily email newsletter.

Leave a Reply